Consequently, increased knowledge will allow further optimized guidance for potency assay development.
The landscape was visually tilted to show the reduced differentiation potency during development.
We compared the development potency of pig NT embryos reconstructed from the pips_m and pips_h cells both in vitro and in vivo.
The engineering of cell-specific enhancers to improve potency and the development of two-step transcriptional activation (TSTA) approaches have significantly improved the efficacy of transgene expression.
Stem cells maintain their unique self-renewal and development potency properties before they initiate differentiation.
Due to their potency at driving development, they are also of great value for stem-cell differentiations in cell culture.
The last group of hnRNPs found in maintenance of stem cell self-renewal and development potency is RNA binding protein EWS (Ewing sarcoma breakpoint 1, also called EWSR1) and FUS (fused in sarcoma, also called TLS/hnRNP P2).
Here, we discuss how strategies for the development of potency assays for TE/RM product candidates may harness potential mechanisms of action or other therapeutically relevant bioactivity along with cell number and viability.
SOX2 is a member of the SRY-related HMG-box (SOX) transcription factor family with a set of well-established and diverse roles in stem cell potency and maintenance, embryonic development and cancer [ 1– 10].
During development, the potency of stem cells is reduced over time from totipotent (morula) to pluripotent (embryonic stem cells) to multipotent (fetal and adult stem cells) to omnipotent (precursor cells) due to progressive gene silencing.
